By Sheri Kasprzak
Atlanta, June 21 - Minrad International, Inc. said it has raised an additional $3 million in a private placement of preferred stock.
The company sold 3,000 shares of series A convertible preferred stock at $1,000 each.
The preferreds pay annual dividends at 6% and are convertible into a total of 1.5 million common shares, or on the basis of 500 common shares for each preferred.
The investors also received warrants for 750,000 shares, exercisable at $3.85 each for three years.
KeyBanc Capital Markets and Chadbourn Securities, Inc. were placement agents.
On June 10, the company raised $7,035,000 from a private placement comprised of 7,035 shares of series A convertible preferred stock at $1,000 each.
Based in Buffalo, N.Y., Minrad is an acute care, medical device and pharmaceutical company.
| Issuer: | Minrad International, Inc.
|
| Issue: | Series A convertible preferred stock
|
| Amount: | $3 million
|
| Shares: | 3,000
|
| Price: | $1,000
|
| Conversion ratio: | Into 1.5 million common shares
|
| Dividend: | 6%
|
| Warrants: | For 750,000 shares
|
| Warrant expiration: | Three years
|
| Warrant strike price: | $3.85
|
| Placement agents: | KeyBanc Capital Markets, Chadbourn Securities, Inc.
|
| Settlement date: | June 21
|
| Stock price: | $3.75 at close June 21
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
